Is DGX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DGX. It does not provide personalized investment advice.

DGX (Quest Diagnostics Inc.) Stock Analysis - Financials

Quest Diagnostics Inc. (DGX) is a publicly traded Healthcare sector company. As of August 23, 2026, DGX trades at $241.25 with a market cap of $26.97B and a P/E ratio of 25.29. DGX moved +1.28% today. Year to date, DGX is +40.83%; over the trailing twelve months it is +33.02%. Its 52-week range spans $148.70 to $245.68. Analyst consensus is buy with an average price target of $252.70. Rallies surfaces DGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are DGX's key financials?

DGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DGX recently traded at $241.25. Market cap is $26.97B. P/E ratio is 25.29. Revenue is $11.56B.

DGX Key Metrics

Key financial metrics for DGX
Metric	Value
Price	$241.25
Market Cap	$26.97B
P/E Ratio	25.29
EPS	$9.54
Dividend Yield	0.86%
52-Week High	$245.68
52-Week Low	$148.70
Volume	733.29K
Avg Volume	0
Revenue (TTM)	$11.56B
Net Income	$1.11B
Gross Margin	33.11%

DGX Analyst Consensus

11 analysts cover DGX: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $252.70.

Common questions about DGX

What are DGX's key financials?: DGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DGX recently traded at $241.25. Market cap is $26.97B. P/E ratio is 25.29. Revenue is $11.56B.
Is DGX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DGX. It does not provide personalized investment advice.